Sana Biotechnology Inc SANA
$3.91 $0.17 (4.55%) 1D
Last Updated: Aug 21, 08:00 PM·NASDAQ
Pricing for US stocks is delayed by 24 hours
SANA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Sana Biotechnology Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Sana Biotechnology Inc. Stock Analysis SANA
United States Health Care Small Cap Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. The company is headquartered in Seattle, Washington and currently employs 142 full-time employees. The company went IPO on 2021-02-04. The company is engaged in developing ex vivo and in vivo cell engineering platforms to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, including type 1 diabetes (T1D), oncology, and B cell mediated autoimmune diseases. The company develops a pipeline of clinical product candidates focused on creating transformative ex vivo therapies across a range of therapeutic areas. Its pipeline products include SC451 and UP421. SC451 is its HIP-edited product candidate for the treatment of type 1 diabetes. SC451 is a pluripotent stem cell (PSC)-derived hypoimmune pancreatic islet cell product candidate for the treatment of diabetes, with an initial focus on T1D. Its ex vivo cell engineering platform is focused on engineering hypoimmune cells that engraft, function, and persist in patients by evading immune rejection.
Sana Biotechnology Inc (SANA) Chart
Financial Metrics & Statements of Sana Biotechnology Inc (SANA)
FAQ's for Sana Biotechnology Inc (SANA)
- As of August 2026, Sana Biotechnology Inc SANA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sana Biotechnology Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Sana Biotechnology Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Sana Biotechnology Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Sana Biotechnology Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Sana Biotechnology Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Sana Biotechnology Inc (SANA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
